SCHEDULE: Suvretta Capital, Averill Master Fund Boost InflaRx Stake

Suvretta Capital Management, LLC and Averill Master Fund, Ltd. have reported significant beneficial ownership in InflaRx N.V., with stakes of 11.7% and 11.4% respectively.

Summary

• Suvretta Capital Management, LLC, Averill Master Fund, Ltd., and Aaron Cowen have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in InflaRx N.V.
• Suvretta Capital Management, LLC and Aaron Cowen (as control person) beneficially own 7,933,910 common shares, representing 11.7% of the class.
• Averill Master Fund, Ltd. beneficially owns 7,723,710 common shares, representing 11.4% of the class.
• All reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.
• The securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of InflaRx N.V.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not contain operational or financial performance data.

Positives

• Increased transparency regarding significant institutional ownership in InflaRx N.V.
• The reporting persons explicitly state that the securities were not acquired for the purpose of changing or influencing control of the issuer, which can reduce uncertainty.

Risks

• This filing is an ownership disclosure and does not detail operational or financial risks of InflaRx N.V.

Future Outlook

This filing is an ownership disclosure and does not contain forward-looking statements or guidance regarding InflaRx N.V.'s operations or financial performance.

Industry Context

StockSavvy.ai notes that significant institutional ownership disclosures, such as this Schedule 13G, often signal increased investor interest in a company within the biotechnology or pharmaceutical sector, where InflaRx N.V. operates. While not an endorsement, such filings provide transparency into the investor base.

Stakeholder Impact

• Shareholders: Increased transparency regarding significant institutional holdings may be viewed positively, potentially signaling confidence from large investors.

Key Dates

Keywords

InflaRx N.V., Suvretta Capital Management, Averill Master Fund, Aaron Cowen, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Shares, N44821101